pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
atebimetinib
atebimetinib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
$IMRX
Immuneering Corp
0
catalysts
Phase 2
ateganosine
Non-Small Cell Lung Cancer
$MAIA
MAIA Biotechnology, Inc.
0
catalysts
Marketed
atenolol
Atenolol (atenolol)
Angina (Angina Pectoris)
AiPing Pharmaceutical Inc
0
catalysts
Phase 2
← prev
page 156 of 231
next →
131
Pain
89
Neurology
1
atesidorsen sodium
Acromegaly
Percheron Therapeutics Ltd
0
catalysts
Marketed
atidarsagene autotemcel
Lenmeldy (atidarsagene autotemcel)
Metachromatic Leukodystrophy (MLD)
Orchard Therapeutics Ltd (Inactive)
0
catalysts
Phase 1
atomoxetine
ATOMOXETINE (atomoxetine [INN])
Attention Deficit Hyperactivity Disorder (ADHD)
Hyloris Pharmaceuticals SA
0
catalysts
Marketed
atomoxetine hydrochloride
Atomoxetine Prasco (atomoxetine hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
Prasco LLC
0
catalysts
Marketed
atorvastatin
Atorvastatin Calcium (atorvastatin [INN])
Cardiovascular Risk Factors
Laurus Labs Ltd
0
catalysts
Marketed
atorvastatin calcium
Atorvaliq (atorvastatin calcium)
Angina (Angina Pectoris)
CMP Pharma Inc
0
catalysts
Marketed
atracurium besylate
Atracurium Besylate (atracurium besylate)
Muscle Relaxation
Meitheal Pharmaceuticals Inc
0
catalysts
Phase 3
atropine
atropine [USP]
Myopia
Ocumension Therapeutics Co Ltd
0
catalysts
Phase 3
atumelnant maleate
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)
$CRNX
Crinetics Pharmaceuticals, Inc.
0
catalysts
Marketed
auranofin
Ridaura (auranofin)
Rheumatoid Arthritis
Legacy Pharma Solutions
0
catalysts
Phase 2
autogene cevumeran
Solid Tumor
Genentech Inc
0
catalysts
Marketed
avacopan
Tavneos (avacopan)
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
ChemoCentryx Inc
0
catalysts
Phase 3
avalglucosidase alfa
Nexviazyme (avalglucosidase alfa)
Pompe Disease
$SNY
Sanofi
0
catalysts
Phase 3
avalotcagene ontaparvovec
Ornithine-Transcarbamylase Deficiency
$RARE
Ultragenyx Pharmaceutical Inc.
0
catalysts
Marketed
avanafil
Stendra (avanafil)
Erectile Dysfunction
Vivus LLC
0
catalysts
Marketed
avapritinib
Ayvakit (avapritinib)
Gastrointestinal Stromal Tumor (GIST)
Blueprint Medicines Corp
0
catalysts
Preclinical
avasimibe
Prader-Willi Syndrome (PWS)
Efil Bioscience Inc
0
catalysts
Marketed
avatrombopag maleate
Doptelet (avatrombopag maleate)
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Thrombopoietin receptor
Swedish Orphan Biovitrum AB
0
catalysts
Phase 2
avenciguat
Systemic Sclerosis (Scleroderma)
Boehringer Ingelheim International GmbH
0
catalysts
Phase 3
avexitide acetate
Hypoglycemia
$AMLX
Amylyx Pharmaceuticals, Inc.
0
catalysts
Phase 2
avicursen
avicursen [INN]
Relapsing Remitting Multiple Sclerosis (RRMS)
Percheron Therapeutics Ltd
0
catalysts
Phase 3
avigbagene parvec
Gaucher Disease Type I
Spur Therapeutics Ltd
0
catalysts
Phase 2
aviptadil
Acute Respiratory Distress Syndrome
Adrenergic receptor alpha
$RLFTY
MindMaze Therapeutics Holding SA
0
catalysts
Phase 2
avoplacel
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
$PLUR
Pluri Inc.
0
catalysts
Marketed
avutometinib potassium
Fallopian Tube Cancer
$VSTM
Verastem, Inc.
0
catalysts
Marketed
avutometinib potassium + defactinib hydrochloride
Avmapki Fakzynja (avutometinib potassium + defactinib hydrochloride)
Ovarian Cancer
$VSTM
Verastem, Inc.
0
catalysts
Marketed
axatilimab
Niktimvo (axatilimab-csfr)
Graft Versus Host Disease (GVHD)
$INCY
INCYTE CORP
0
catalysts
